Skip to main navigation Skip to search Skip to main content

Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third Monaciano Symposium

  • on behalf of the Monaciano Consortium
  • University of Michigan Medical School
  • King’s College London
  • IRCCS Bambino Gesù Children’s Hospital
  • Duke University School of Medicine
  • Sorbonne Université
  • Centre Hospitalier National D’Ophtalmologie des Quinze Vingts
  • Telethon Institute of Genetics and Medicine
  • UCL Institute of Ophthalmology
  • Hadassah-Hebrew University Medical Center
  • Retina Foundation of the Southwest
  • University of Pennsylvania
  • University of Texas Health Science Center-Houston
  • University of California San Francisco
  • University of California-Berkeley
  • Israelitic Hospital
  • Hospital for Sick Children
  • Inc.
  • University of North Carolina School of Medicine
  • University of California-Irvine
  • Ghent University Hospital & Ghent University
  • Children’s Hospital of Philadelphia
  • University of Trieste
  • Moorfields Eye Hospital NHS Foundation Trust
  • Oregon Health Science Center
  • Michigan State University
  • Beth Israel Deaconess Medical Center and Harvard Medical School
  • Fondation Ophtalmologique
  • University of Pittsburgh School of Medicine
  • University of California-Davis School of Medicine
  • CNR Neuroscience Institute
  • University of Washington

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article number37
JournalTranslational Vision Science and Technology
Volume14
Issue number8
DOIs
StatePublished - Aug 2025

ASJC Scopus Subject Areas

  • Biomedical Engineering
  • Ophthalmology

Keywords

  • clinical trials
  • gene therapy
  • inherited blindness
  • outcome measures
  • patient support

Cite this